TĂNG HUYẾT ÁP KHÁNG TRỊ .GS BS. ĐỖ DOÃN LỢI. VT Viện Tim mạch Việt Nam. PCT Hội Tim mạch Việt Nam

TĂNG HUYẾT ÁP KHÁNG TRỊ GS BS ĐỖ DOÃN LỢI VT Viện Tim mạch Việt Nam PCT Hội Tim mạch Việt Nam THA tần suất không đạt mục tiêu Tần suất điều trị không đạt mục tiêu THA US 59% Canada 972 triệu (26%) 71% England Năm 2000 47% Germany 1.56 tỷ (29%) 2025* 66% Greece 50% 84% Spain Japan 500 1000 1500 39% 10 20 30 40 50 60 70 80 90 *Projected Most of the expected increase will be in economically developing regions † Based on a literature search of the MEDLINE database of studies from January 1980 through July 2003 Kearney PM, et al Lancet 2005;365:217-223 Power Over Pressure Volume 370, Issue 9587, August 18, 2007, Page www.poweroverpressure.com 539 Kearney PM, et al J Hypertens 2004; 22:11-19 Nguy tim mạch tăng Biến cố tim mạch (sau năm) Bn đạt mục tiêu THA kháng trị 5% 19% Note: Study did not include outcomes in untreated hypertensives or in patients with uncontrolled hypertension on 1-2 antihypertensive medications CV=cardiovascular Adapted from Pierdomenico SD, et al Am J Hypertens 2005;18:1422-1428 Power Over Pressure www.poweroverpressure.com Rationale for antihypertensive treatment: reduce CV risk Impact of High-Normal Blood Pressure on Risk of Major Cardiovascular Events in Men Cumulative Incidence of Major Cardiovascular Events (%) 16 Blood Pressure: 14 High-Normal (N=903) 12 130-139 / 85-89 mm Hg Normal (N=1059) 10 120-129/80-84 mm Hg Optimal (N=1005)